Singapore markets closed

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
23.050+0.300 (+1.32%)
At close: 04:08PM HKT
Currency in HKD

Valuation measures4

Market cap (intra-day) 54.52B
Enterprise value 42.37B
Trailing P/E 8.39
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)0.46
Price/book (mrq)1.04
Enterprise value/revenue 0.60
Enterprise value/EBITDA 7.86

Trading information

Stock price history

Beta (5Y monthly) 0.70
52-week change 39.11%
S&P500 52-week change 3-9.23%
52-week high 326.000
52-week low 316.560
50-day moving average 322.796
200-day moving average 320.662

Share statistics

Avg vol (3-month) 31.67M
Avg vol (10-day) 3538.28k
Shares outstanding 5219.9M
Implied shares outstanding 6N/A
Float 8837.93M
% held by insiders 10.00%
% held by institutions 133.93%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.81
Forward annual dividend yield 43.54%
Trailing annual dividend rate 30.69
Trailing annual dividend yield 33.02%
5-year average dividend yield 42.54
Payout ratio 428.79%
Dividend date 3N/A
Ex-dividend date 410 Jun 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Sept 2022

Profitability

Profit margin 5.52%
Operating margin (ttm)5.43%

Management effectiveness

Return on assets (ttm)3.56%
Return on equity (ttm)12.81%

Income statement

Revenue (ttm)70.28B
Revenue per share (ttm)43.23
Quarterly revenue growth (yoy)1.00%
Gross profit (ttm)13.19B
EBITDA 4.2B
Net income avi to common (ttm)3.88B
Diluted EPS (ttm)2.760
Quarterly earnings growth (yoy)9.30%

Balance sheet

Total cash (mrq)21.72B
Total cash per share (mrq)13.36
Total debt (mrq)11.3B
Total debt/equity (mrq)33.34
Current ratio (mrq)1.65
Book value per share (mrq)19.33

Cash flow statement

Operating cash flow (ttm)3.19B
Levered free cash flow (ttm)-956.55M